This site is intended for UK healthcare professionals only

NEWS

 

Keep up to date with the latest news on bladder health, management and treatment.

Have you got a story to share? Email the team today.

Artificial Intelligence used in bladder cancer treatment assessment

Artificial Intelligence used in bladder cancer treatment assessment

A computerised artificial intelligence (AI)-based decision support system (CDSS-T) enhanced the performance of ...
New treatment for urothelial cancer approved by NICE

New treatment for urothelial cancer approved by NICE

Over 800 people with locally advanced or metastatic urothelial cancer are set to benefit from a new treatment for ...
β-Lactam antibiotics useful for UTI despite β-Lactamase-producing bacteria

β-Lactam antibiotics useful for UTI despite β-Lactamase-producing bacteria

Noncarbapenem β-lactam antibiotics (intravenous) appeared effective in treating urinary tract infection (UTI) from ...
Can a common childhood virus cause bladder cancer?

Can a common childhood virus cause bladder cancer?

A common childhood viral infection causes damage to cells in the bladder which may lead to cancer, a new study has ...
Yale Cancer Center study validates new therapy for aggressive bladder cancer

Yale Cancer Center study validates new therapy for aggressive bladder cancer

Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in patients ...
LEGEND study results released exploring Non-Muscle Invasive Bladder Cancer (NMIBC)

LEGEND study results released exploring Non-Muscle Invasive Bladder Cancer (NMIBC)

enGene Announces Positive Preliminary Phase 1/2 Data with EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder ...
Could artificial intelligence aid bladder cancer diagnosis and outcome prediction?

Could artificial intelligence aid bladder cancer diagnosis and outcome prediction?

A recent study reports that AI models have shown great promise in bladder cancer diagnosis and outcome ...
Erdafitinib efficacy in bladder cancer sustained with long-term follow-up

Erdafitinib efficacy in bladder cancer sustained with long-term follow-up

Long-term follow-up from the pivotal phase 2 BLC2001 study showed continued efficacy with the pan-FGFR inhibitor ...